Quantcast

Latest CSL Limited Stories

2014-02-20 08:32:25

International study by CSL Behring is world's first placebo-controlled phase III trial to examine subcutaneous administration of C1-INH for use in treating rare, sometimes life-threatening, condition KING OF PRUSSIA, Pa., Feb. 20, 2014 /PRNewswire/ -- CSL Behring today announced it has enrolled the first patient in COMPACT, an international phase III study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor (C1-INH) concentrate in patients with frequent hereditary...

2014-02-17 08:25:07

LONDON, Feb. 17, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Medical Device Leader Series: Top Needle-Free Injection Device Manufacturers 2014-2024 Report Details Needle-free injecting technologies - discover activities, developments, and prospects of leading companies What does the future hold for makers of needle-free injection (NFI) products? See what's possible. Visiongain's updated report shows you data to 2024 for that industry and...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related